SCHEMBL5228875

SCHEMBL5228875

CC(=O)ON(Cc1cccc(OCCc2nc(-c3ccc(C)cc3)oc2C)c1)S(=O)(=O)N1CCc2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 19/20 0.51
PPARG P37231 18/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5223343 0.96 PPARA (0.56) PPARAPPARG
SCHEMBL5228999 0.93 PPARA (0.50) PPARAPPARG
SCHEMBL5229106 0.92 PPARG (0.51) PPARAPPARG
SCHEMBL5226643 0.89 KDR (0.52) PPARAPPARG
SCHEMBL5227814 0.89 PPARA (0.46) PPARAPPARG
SCHEMBL5263970 0.89 PPARA (0.49) PPARAPPARG
SCHEMBL5223524 0.88 PPARA (0.59) PPARAPPARG
SCHEMBL5259761 0.87 PPARA (0.53) PPARAPPARG
SCHEMBL5227322 0.86 PPARG (0.54) PPARAPPARG
SCHEMBL5263579 0.86 TP53 (0.53) PPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778654-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME Crystalgenomics, Inc. (KR) 2007-05-02 EP disclosed
WO-2006006832-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME CRYSTALGENOMICS, INC. (KR) 2006-01-19 WO disclosed